Yifeng Pharmacy Chain Co Ltd Class A

Yifeng Pharmacy Chain Co Ltd Class A

SSSE:603939
26.61
CNY
+0.44
(+1.68%)
1.59EPS
15.58P/E
28.26BMarket Cap
Apr 23Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
2.47
3.06
3.02
3.62
4.33
6.21
8.92
11.36
12.84
16.55
18.72
19.83
20.09
20.91
Basic EPS, GAAP
0.14
0.19
0.19
0.22
0.28
0.37
0.47
0.64
0.74
1.05
1.17
1.26
1.38
1.5
Free Cash Flow per Basic Share
0.14
0.16
0.02
-0.11
0.1
0.25
0.44
1.51
1.11
2.77
3.22
2.92
2.5
- -
Dividend per Share
0.03
0.07
0.08
- -
0.05
0.16
0.14
0.14
0.18
0.2
0.27
0.7
0.7
0.7
Book Value per Share
0.68
0.8
1.44
2.67
2.86
3.52
3.89
4.62
6.2
7.05
8.08
8.85
9.6
9.91
Tangible Book Value per Share
0.51
0.64
1.1
2.05
2.06
0.93
0.96
1.42
2.79
3.2
3.89
4.51
5.26
5.57
Basic Weighted Avg Shares
731
728
944
1,033
1,109
1,113
1,152
1,157
1,193
1,202
1,207
1,213
1,216
1,214
Sales/Revenue/Turnover
1,804
2,230
2,846
3,734
4,807
6,913
10,276
13,145
15,326
19,886
22,588
24,062
24,433
25,383
Operating Margin (%)
7.42
8.41
7.71
7.59
8.4
7.9
8.41
9.76
9.51
10.19
9.45
9.64
10.29
10.93
Depreciation Expense
21
22
27
38
50
70
95
942
1,191
1,441
1,649
1,883
1,750
- -
Net Income, GAAP
99
141
176
224
314
416
544
744
888
1,262
1,412
1,529
1,678
1,816
Effective Tax Rate (%)
25.71
25.57
25.61
25.48
25.84
24.03
25.23
25.54
25.95
24.18
22.41
24.27
25.46
25.11
Profit Margin (%)
5.5
6.3
6.18
6
6.52
6.02
5.29
5.66
5.79
6.35
6.25
6.35
6.87
7.15
Working Capital
186
242
728
1,926
1,799
1,345
1,261
1,795
1,171
919
859
3,258
5,073
5,803
LT Debt
- -
- -
- -
- -
- -
746
687
3,743
2,390
2,180
2,339
3,914
3,256
3,048
Total Equity
502
596
1,419
2,975
3,180
4,170
4,709
5,663
7,865
9,119
10,447
11,394
12,379
12,853
Return on Invested Capital (%)
20.39
23.98
16.69
9.86
10.13
10.51
11.36
10.34
8.96
11.8
11.67
10.61
10.72
11.78
Return on Capital (%)
21.12
25.24
16.3
10.02
10.06
9.8
9.82
8.78
8.36
10.31
10.2
10.17
9.86
10.03
Return on Common Equity (%)
21.55
25.83
17.58
10.24
10.23
11.53
12.69
15.07
13.83
15.74
15.38
14.89
15.01
15.67

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
1,081
1,042
1,031
LT Borrowings
1,664
1,674
1,684
LT Finance Leases
1,531
1,430
1,364
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,212
1,212
1,212
Market Capitalization
29,582
21,799
28,261

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
16,388
15,548
16,169
Cash, Cash Equivalents & STI
9,354
8,932
9,549
Accounts Receivable, Net
1,790
1,607
1,493
Inventories
4,207
4,081
4,046
Total Current Liabilities
10,657
9,704
10,366
Payables & Accruals
- -
- -
- -
ST Debt
1,081
1,042
1,031
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
26.79%
17.42%
8.65%
Free Cash Flow
-29.77%
24.23%
-14.22%
Net Income, GAAP
25.89%
18.3%
9.81%
Sales/Revenue/Turnover
24.83%
13.6%
1.54%
Total Cash Common Dividend
- -
48.07%
0.33%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
5,971
5,791
5,456
6,843
24,062
2025
6,009
5,713
- -
7,147
24,433
2026
6,085
6,045
6,106
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.33
0.32
0.26
0.34
1.26
2025
0.37
0.36
- -
0.37
1.38
2026
0.41
0.38
0.33
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.25
0.17
0.28
0.7
2025
- -
0.41
- -
- -
0.7
2026
0.01
0.4
0.3
- -
- -

Company Description

CEO
Yi Gao
Full Time Employees
38,953
Sector
Retail trade
Industry
Drugstore chains
Address
No.68, Jinzhou Avenue Changsha HU China 410000
IPO Date
Feb 9, 2015
Website
yfdyf.com
Business
Yifeng Pharmacy Chain Co., Ltd. (603939:SHH) operates as a leading pharmaceutical retail chain in China, primarily engaged in the retailing and wholesaling of pharmaceuticals, health products, medical devices, and related consumer goods through an extensive network of stores and digital channels. The company offers Western and Chinese patent medicines, traditional Chinese medicine herbal pieces, medical devices and equipment, health supplements and products, personal care products, drugs, convenience products related to health, maternal and child products, daily necessities, and household cleaning products; it also provides chronic disease management services, medical project investment, medical technology development, internet hospital operations, franchise distribution, and e-commerce platforms. Yifeng Pharmacy Chain maintains a significant presence across Central South China, East China, and North China, including provinces such as Hunan, Hubei, Shanghai, Jiangsu, Zhejiang, Jiangxi, Guangdong, Hebei, and Beijing, with approximately 40,000 employees supporting over 6,000 stores. Founded in 2001 and headquartered at No. 68 Jinzhou Avenue, Lugu High-Tech Zone, Changsha, China, the company listed on the Shanghai Stock Exchange in 2015 and operates through its key subsidiary, Hunan Yifeng Pharmaceutical Co., Ltd., for wholesale activities. In recent developments, Yifeng Pharmacy Chain completed the acquisition of a 51% stake in Hunan Jiuzhitang Pharmaceutical Co., Ltd. from Jiuzhitang Co., Ltd.; it achieved a net increase of 2,512 stores in 2024 through a city-specific strategy of new openings, mergers and acquisitions, and franchising while closing inefficient outlets; the company upgraded its electronic prescription transfer services, integrated over 4,600 pharmacies with outpatient medical insurance systems, established partnerships with nearly 200 specialized prescription drug suppliers, and enhanced its digital platform interfacing with over 50 hospital systems including internet hospitals.